Critical Care Reviews Podcast

Drs Mikael Fink Vallentin and Lars Andersen (University of Aarhus, Denmark) present the results of the COCA trial, investigating calcium for out-of-hospital cardiac arrest. The COCA trial results were presented at a Critical Care Reviews Trial Results Presentation Livestream on November 30th, 2021, with a simultaneous publication in JAMA.

Prof Gavin Perkins (University of Warwick) delivers an editorial on the COCA trial, investigating calcium for out-of-hospital cardiac arrest. The COCA trial results were presented at a Critical Care Reviews Trial Results Presentation Livestream on November 30th, 2021, with a simultaneous publication in JAMA.

Dr Bharath Kumar presents preliminary results of the HOPE trial and discusses the difficulties of undertaking research during a pandemic.

Bram Rochwerg (Hamilton, Canada), Paul Mouncey (London, England) & Colin McArthur (Auckland, New Zealand) join trialists Sheila Nainan Myatra (Mumbai, India), Bala Ventakesh (Brisbane, Australia) and Anders Perner (Copenhagen, Denmark), as well as editorialists Marion Campbell (Aberdeen, Scotland), to discuss the COVID STEROID 2 trial.

Chris Nutt (Belfast) asks investigators Sheila Nainan Myatra, Bala Venkatesh & Anders Perner questions from the viewers during the D STEROID 2 Trial Results Presentation. This trial result was presented at a Critical Care Reviews Trial Results Livestream, on October 21st, 2021

Prof Marion Campbell (Aberdeen, Scotland) delivers an editorial on the COVID STEROID 2 Trial, comparing 12mg with 6mg of dexamethasone in patients with severe COVID-19 and hypoxia, at a Critical Care Reviews Trial Result Livestream, on October 21st, 2021.

Sheila Nainan Myatra (Mumbai, India), Bala Ventakesh (Brisbane, Australia), Anders Perner (Copenhagen, Denmark) present the results of the COVID STEROID 2 Trial, comparing 12mg with 6mg of dexamethasone in patients with severe COVID-19 and hypoxia, at a Critical Care Reviews Trial Result Livestream, on October 21st, 2021.

Chief investigator Lars Andersen joins Rob Mac Sweeney to address some of the questions and comments that arose following the presentation and publication of the VAM-IHCA trial results, investigating vasopressin and methylprednisolone for in-hospital cardiac arrest.

Rob Mac Sweeney (Belfast) hosts an expert panel to discuss the findings of the VAM-IHCA trial, investigating vasopressin and methylprednisolone for in-hospital cardiac arrest. The panel consists of Katherine Berg (Boston), Bernd Botttiger (Cologne), Ranjit Lall (Coventry), Louise Morrison (Toronto), Spyros Mentzelopoulos (Athens), Lars Wiuff Andersen & Asger Granfeldt (Aarhus), and Spyros Mentzelo...

Chris Nutt (Belfast) poses questions from the viewers to the lead investigators of the VAM-IHCA trial, Lars Wiuff Andersen and Asger Granfeldt. This trial result was presented at a Critical Care Reviews Trial Results Livestream, on September 29th, 2021.

Prof Spyros Mentzelopoulos (Athens, Greece) delivers an independent editorial on the VAM-IHCA trial, investigating vasopressin and methylprednisolone for in-hospital cardiac arrest. This trial result was presented at a Critical Care Reviews Trial Results Livestream, on September 29th, 2021

Asger Granfeldt & Lars Wiuff Andersen (Aarhus, Denmark) present the results of the VAM-IHCA trial, investigating the combination of vasopressin and methylprednisolone for in-hospital cardiac arrest. This trial result was presented at a Critical Care Reviews Trial Results Livestream, on September 29th, 2021.

Prof Alistair Nichol (Dublin & Melbourne) discusses why the REMAP-CAP adaptive platform trial has chosen to investigate ivermectin, given the controversy surrounding this agent.

Dr Lennie Derde is the Trial Steering Committee Chair and the European Coordinating Investigator for the REMAP-CAP project. She discusses the running of the REMAP-CAP trial, her background in critical care and infectious diseases, how she got into critical care research, the background of the REMAP-CAP trial and its current workload for her. We also review the output from the trial to date and fin...

BaSICS trial leads Drs Fernando Zampieri & Alexandre Biasi Cavalcante join Rob Mac Sweeney to address some of the questions and comments that arose following the presentation and publication of the BaSICS trial results.

Niklas Nielsen, the chief investigator for the TTM2 trial, joins Rob Mac Sweeney to address some of the questions and comments that arose following the presentation and publication of the TTM2 trial results.

Prof Manu Shankar-Hari, the lead for the WHO REACT group's prospective meta analysis on interleukin 6 antagonism in patients hospitalised with COVID-19, joins Rob Mac Sweeney to discuss this important work

Prof Giuseppe Citerio (Milan) joins Rob Mac Sweeney to discuss  the global SYNAPSE-ICU study, investigating the use of intracranial pressure monitoring in acute brain injury.

Phil Gillen (Belfast) asks questions posed by the viewers of the TTM2 results livestream to the TTM2 trialists Niklas Nielsen, Josef Dankiewicz and Gisela Lilja.

Niklas Nielsen, Josef Dankiewicz and Gisela Lilja (all Lund) presents the results of the landmark TTM2 trial, comparing hypothermia (33°) with normothermia (

Panellists Jerry Nolan, Kathy Rowan and Terri Hough join editorialist Stephen Bernard and TTM2 investigators Niklas Nielsen, Josef Dankiewicz and Gisela Lilja to discuss the landmark TTM2 trial at the Critical Care Reviews hosted TTM2 results livestream.

Prof Stephen Bernard (Melbourne) delivers an editorial on the TTM2 trial result, delivered as part of the Critical Care Reviews hosted TTM2 Trial Results Livestream.

Prof Derek Angus, from Pittsburgh, USA, discusses a modern healthcare system which merges research into clinical practice, producing a "learning while doing" healthcare model.

Professor Kath Maitland joins Rob Mac Sweeney to discuss the COAST trial, investigating oxygen therapy in African children with severe pneumonia.

In the latest episode on the REMAP-CAP series, Prof Alistair Nichol (Dublin / Melbourne) discuss the upcoming ventilation domain with Rob Mac Sweeney.